Bridging of antithrombotic therapy in patients with cardiovascular disease. Position paper;Unterbrechung antithrombotischer behandlung (Bridging) bei kardialen Erkrankungen. Positionspapier

Kardiologe

Volumn 4, Issue 5, 2010, Pages 365-374

  Hoffmeister, H M ^a   Bode, C ^a   Darius, H ^a   Huber, K ^a   Rybak, K ^a   Silber, S ^a  

^a STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

Author keywords

Anticoagulation; Antiplatelet therapy; Antithrombotic therapy; Bridging; Periprocedural management

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CORONARY STENT; ELECTIVE SURGERY; EMERGENCY SURGERY; HEART VALVE REPLACEMENT; HIGH RISK PATIENT; HUMAN; IMPLANTATION; PERIOPERATIVE PERIOD; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; TREATMENT DURATION;

EID: 78650434089     PISSN: 18649718     EISSN: 18649726     Source Type: Journal    
DOI: 10.1007/s12181-010-0294-y     Document Type: Article

References (44)

1. Douketis JD, Berger PB, Dunn AS et al (2008) The perioperative management of antithrombotic therapy (ACCP Evidence-based clinical practice guidelines, 8th Edition). Chest 133:299-339
2. Silber S, Borggrefe M, Böhm M et al (2007) Positionspapier der DGK zur Wirksamkeit und Sicherheit von Medikamente freisetzenden Koronarstents (DES). Kardiologe 2:84-111
3. Silber S, Borggrefe M, Böhm M et al (2008) Medikamente freisetzende Koronarstents (DES) und Medikamente freisetzende Ballonkatheter (DEB): Aktualisierung des Positionspapiers der DGK. Clin Res Cardiol 97:548-563
4. De Caterina R, Husted S, Wallentin L et al (2007) Anticoagulants in heart disease: current status and perspectives. Eur Heart J 28:880-913
5. Bassand JP, Hamm CW, Ardissino D et al (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28:1598-1660
6. Van de Wef F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 29:2909-2945
7. Silber S, Albertsson P, Avilès F et al (2005) Guidelines for percutaneous coronary interventions. Eur Heart J 26:804-847 (Pubitemid 40547082)
8. Fuster V, Rydèn LE, Cannorn DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary. Eur Heart J 27:1979-2030
9. Fleisher LA, Beckman JA, Brown KA et al (2007) Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Circulation 116:1971-1996
10. Grines CL, Bonow RO, Casey DE et al (2007) Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. Circulation 115:813-818
11. King SB III, Smith SC, Hirshfeld JW et al (2008) 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Circulation 117:261-299
12. Antman EM, Hand M, Armstrong PW et al (2008) 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 117:296-329
13. Poldermans D, Bax JJ, Boersma e et al (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in noncardiac surgery. Eur Heart J 30:2769-2812
14. Dunning J, Versteegh M, Fabbri A et al (2008) Guidelines on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 34:73-92
15. Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease. Eur Heart J 28:230-268
16. Wysokinski WE, McBane RD, Daniels PR et al (2008) Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc 83:639-645
17. Garcia DA, Regan S, Henault LE et al (2008) Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 168:63-69
18. Whitlock R P, Crowther MA, Warkentin TE et al (2007) Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K. Ann Thorac Surg 84:103-109
19. Rivas-Gándara N, Ferreira-Gonzàlez I, Tornos P et al (2008) Enoxaparin as bridging anticoagulant treatment in cardiac surgery. Heart 94:205-210
20. Renda G, Di Pillo R, D'Alleva A et al (2007) Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery. Haematologica 92:366-373
21. O'Donnell MJ, Kearon C, Johnson J et al (2007) Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin (Brief Communication). Ann Intern Med 146:184-187
22. Spyropoulos AC, Bauersachs RM, Omran H et al (2008) Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin 22:1109-1122
23. Meurin P, Tabet JY, Weber H et al (2006) Low-molecular - weight heparin as a bridging anticoagulant early after mechanical heart valve replacement. Circulation 113:564-569
24. Ho PM, Peterson ED, Wang L et al (2008) Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 299:532-539
25. Möllmann H, Nef HM, Hamm CW et al (2009) How to manage patients with need for antiplatelet therapy in the setting of (un)-planned surgery. Clin Res Cardiol 98:8-15
26. Silber S, Hoffmeister HM, Bode C (2008) Optimale Thrombozytenaggregationshemmung nach koronarer Stentimplantation. Herz 33:244-253
27. Omran H, Hammerstingl C, Paar WD (2007) Perioperative überbrückende Antikoagulation mit Enoxaparin. Ergebnisse des prospektiven BRAVE-Registers mit 779 Patienten. Med Klin 102:809-815
28. Jaffer AK, Brotman DJ, Badh LD et al (2010) Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med 123:141-150
29. Savonitto S, Urbano MD, Caracciolo M et al (2010) Urgent surgery in patients with recently implanted coronary drug-eluting stent: a phase II study of bridging antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth 104:285-291
30. Lepper W, Kelm M (2007) Perioperative Therapie mit Thrombozytenaggregationshemmern. Anaesthesist 56:592-598
31. Jámbor C, Spannagl, Zwissler B (2009) Perioperatives Management von Patienten mit Koronarstents bei nichtherzchirurgischen Eingriffen. Anaesthesist 58:971-985
32. Koscielny J, Ziemer S, Heymann C von (2009) Patients with oral anticoagulation. Bridging anticoagulation in the perioperative phase. Hamostaseologie 29:247-255
33. Chou S, Eshaghian S, Lamer A et al (2009) Bridging therapy in the perioperative management of patients with drug-eluting stents. Rev Cardiovasc Med 10:209-218
34. Tischenko A, Gula LJ, Yee R et al (2009) Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Am Heart J 158:252-256
35. Rammer M, Punzengruber C, Weber T et al (2009) Management der oralen Antikoagulation bei Operationen und anderen invasiven Eingriffen. J Cardiol 16:417-421
36. Strebel N, Prins M, Agnelli G et al (2002) Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecularweight heparin in elective hip surgery? Arch Intern Med 162:1451-1456
37. Dunn AS, Spyropoulos AC, Turpie AG (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 5:2211-2218
38. Cheng M, Hua W, Chen K et al (2009) Perioperative anticoagulation for patients with mechanic heart valve (s) undertaking pacemaker implantation. Europace 11:1183-1187
39. Gage BF, Waterman AD, Shannon W et al (2001) Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillaton. JAMA 285:2864-2870
40. Herrath D, Ludwig WD, Thimme W (Hrsg) (2010) Perioperatives Arzneimittelmanagement: Hemmung der Thrombozytenfunktion bei kardiovaskulären Krankheiten. Arzneimittelbrief 44:17-19
41. Kuijk JP van, Flu WJ, Schouten O et al (2009) Timing of noncardiac surgery after coronary artery stenting with bare metal or drug eluting stents. Am J Cardiol 104:1229-1234
42. Spyropoulos AC, Turpie AG, Dunn AS et al (2008) Perioperative bridging therapy with unfractionated heparin or low-molecular weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulations. Am J Cardiol 102:883-889
43. Halbritter KM, Waver A, Beyer J et al (2005) Bridging anticoagulation for patients on long-term vitamin K-antagonists. A prospective 1 year registry of 311 episodes. J Thromb Haemost 3:2823-2825
44. American Society for Gastrointestinal Endoscopy (2002) Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 55:775-779